TIMP3 and diabetes mellitus: This finding suggests that TIMP3 overexpression in cells of the myeloid lineage may confer an improved inflammatory profile in the endocrine pancreas, as multiple low doses STZ causes diabetes by destroying insulin‐producing β‐cells through inflammatory mechanisms.37